<VariationArchive RecordType="classified" VariationID="974678" VariationName="NM_000619.3(IFNG):c.354_357del (p.Thr119fs)" VariationType="Deletion" Accession="VCV000974678" Version="3" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2022-03-28" MostRecentSubmission="2022-03-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="962973" VariationID="974678">
      <GeneList>
        <Gene Symbol="IFNG" FullName="interferon gamma" GeneID="3458" HGNC_ID="HGNC:5438" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q15</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="68154768" stop="68159740" display_start="68154768" display_stop="68159740" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="68548549" stop="68553520" display_start="68548549" display_stop="68553520" Strand="-" />
          </Location>
          <OMIM>147570</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000619.3(IFNG):c.354_357del (p.Thr119fs)</Name>
      <CanonicalSPDI>NC_000012.12:68157921:AGTCAG:AG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q15</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="68157922" stop="68157925" display_start="68157922" display_stop="68157925" variantLength="4" positionVCF="68157921" referenceAlleleVCF="TAGTC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="68551702" stop="68551705" display_start="68551702" display_stop="68551705" variantLength="4" positionVCF="68551701" referenceAlleleVCF="TAGTC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>T119fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.68551704_68551707del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.68551704_68551707del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.68157924_68157927del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.68157924_68157927del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015840.1" sequenceAccession="NG_015840" sequenceVersion="1" change="g.6817_6820del">
            <Expression>NG_015840.1:g.6817_6820del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000619.3" sequenceAccession="NM_000619" sequenceVersion="3" change="c.354_357del" MANESelect="true">
            <Expression>NM_000619.3:c.354_357del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000610.2" sequenceAccession="NP_000610" sequenceVersion="2" change="p.Thr119fs">
            <Expression>NP_000610.2:p.Thr119fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="147570.0005" DB="OMIM" />
        <XRef Type="rs" ID="1882625482" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000619.3(IFNG):c.354_357del (p.Thr119fs) AND Immunodeficiency 69" Accession="RCV001250909" Version="3">
        <ClassifiedConditionList TraitSetID="55950">
          <ClassifiedCondition DB="MedGen" ID="C5436498">Immunodeficiency 69</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-03-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-23" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2022-03-28">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">32163377</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="55950" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="53865" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">IMMUNODEFICIENCY 69, MYCOBACTERIOSIS, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="618963" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">IFNG DEFICIENCY, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="618963" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Immunodeficiency 69</ElementValue>
                <XRef ID="MONDO:0033541" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">IMD69</ElementValue>
                <XRef Type="MIM" ID="618963" DB="OMIM" />
              </Symbol>
              <XRef ID="C5436498" DB="MedGen" />
              <XRef ID="MONDO:0033541" DB="MONDO" />
              <XRef Type="MIM" ID="618963" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2814373" SubmissionDate="2022-03-23" DateLastUpdated="2022-03-28" DateCreated="2020-08-03">
        <ClinVarSubmissionID localKey="147570.0005_IMMUNODEFICIENCY 69 (1 family)" title="IFNG, 4-BP DEL, NT354_IMMUNODEFICIENCY 69 (1 family)" />
        <ClinVarAccession Accession="SCV001426386" DateUpdated="2022-03-28" DateCreated="2020-08-03" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-23">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamilies="1" />
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 patients from a large consanguineous kindred of Lebanese descent with autosomal recessive immunodeficiency-69 (IMD69; 618963) manifest as increased susceptibility to mycobacterial disease, Kerner et al. (2020) identified a homozygous 4-bp deletion (c.354_357del) in exon 3 of the IFNG gene, predicted to result in a frameshift and premature termination (Thr119IlefsTer4). The mutation, which was found by a combination of homozygosity mapping and whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. It was not found in the gnomAD database or in an in-house database of over 6,000 individuals. Patient cells showed decreased levels of IFNG mRNA compared to controls, suggesting some mRNA decay of the mutant transcript. The predicted truncated protein, if expressed, would lack the C-terminal domain and likely be nonfunctional. In vitro functional expression studies of patient T and NK cells and cells transfected with the mutation showed impaired production of gamma-interferon when stimulated, and impaired induction of HLA-DR expression compared to controls, consistent with a complete loss of IFNG function. These cellular defects could be partially rescued by expression of wildtype IFNG.</Attribute>
              <Citation>
                <ID Source="PubMed">32163377</ID>
              </Citation>
              <XRef DB="OMIM" ID="618963" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IFNG" />
          </GeneList>
          <Name>IFNG, 4-BP DEL, NT354</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, NT354</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="147570.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">IMMUNODEFICIENCY 69 (1 family)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
  </ClassifiedRecord>
</VariationArchive>

